Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Perspective on Systematic Literature Reviews and Meta-Analyses.

Pepose JS, Foulks GN, Nelson JD, Erickson S, Lemp MA.

Am J Ophthalmol. 2019 Dec 4. pii: S0002-9394(19)30592-6. doi: 10.1016/j.ajo.2019.11.028. [Epub ahead of print]

PMID:
31811861
2.

Human Meibum Cholesteryl and Wax Ester Variability With Age, Sex, and Meibomian Gland Dysfunction.

Borchman D, Ramasubramanian A, Foulks GN.

Invest Ophthalmol Vis Sci. 2019 May 1;60(6):2286-2293. doi: 10.1167/iovs.19-26812.

3.

TFOS DEWS II Clinical Trial Design Report.

Novack GD, Asbell P, Barabino S, Bergamini MVW, Ciolino JB, Foulks GN, Goldstein M, Lemp MA, Schrader S, Woods C, Stapleton F.

Ocul Surf. 2017 Jul;15(3):629-649. doi: 10.1016/j.jtos.2017.05.009. Epub 2017 Jul 20. Review.

PMID:
28736344
4.

TFOS DEWS II Introduction.

Nelson JD, Craig JP, Akpek EK, Azar DT, Belmonte C, Bron AJ, Clayton JA, Dogru M, Dua HS, Foulks GN, Gomes JAP, Hammitt KM, Holopainen J, Jones L, Joo CK, Liu Z, Nichols JJ, Nichols KK, Novack GD, Sangwan V, Stapleton F, Tomlinson A, Tsubota K, Willcox MDP, Wolffsohn JS, Sullivan DA.

Ocul Surf. 2017 Jul;15(3):269-275. doi: 10.1016/j.jtos.2017.05.005. Epub 2017 Jul 20. Review. No abstract available.

PMID:
28736334
5.

Progressively Increased Variation in Tear Osmolarity Mirrors Dry Eye Severity.

Sullivan BD, Pepose JS, Foulks GN.

JAMA Ophthalmol. 2015 Dec;133(12):1481-2. doi: 10.1001/jamaophthalmol.2015.3854. No abstract available.

PMID:
26469765
6.

Clinical guidelines for management of dry eye associated with Sjögren disease.

Foulks GN, Forstot SL, Donshik PC, Forstot JZ, Goldstein MH, Lemp MA, Nelson JD, Nichols KK, Pflugfelder SC, Tanzer JM, Asbell P, Hammitt K, Jacobs DS.

Ocul Surf. 2015 Apr;13(2):118-32. doi: 10.1016/j.jtos.2014.12.001. Epub 2015 Jan 15. Review.

PMID:
25881996
7.

Changes in The Ocular Surface through technology and time.

Foulks GN.

Ocul Surf. 2015 Jan;13(1):1-2. doi: 10.1016/j.jtos.2014.11.001. Epub 2014 Nov 15. No abstract available.

PMID:
25557340
8.

Understanding ocular surface disease from uncommon to extremely common afflictions.

Foulks GN.

Ocul Surf. 2014 Oct;12(4):233. doi: 10.1016/j.jtos.2014.08.001. Epub 2014 Aug 12. No abstract available.

PMID:
25284769
9.

Back to basics.

Foulks GN.

Ocul Surf. 2014 Jul;12(3):161. doi: 10.1016/j.jtos.2014.05.003. Epub 2014 May 21. No abstract available.

PMID:
24999098
10.

Rethinking dry eye disease: a perspective on clinical implications.

Bron AJ, Tomlinson A, Foulks GN, Pepose JS, Baudouin C, Geerling G, Nichols KK, Lemp MA.

Ocul Surf. 2014 Apr;12(2 Suppl):S1-31. doi: 10.1016/j.jtos.2014.02.002. Epub 2014 Feb 13. Review.

PMID:
24725379
11.

Pro·voc·a·tive: causing discussion, thought, argument, etc.

Foulks GN.

Ocul Surf. 2014 Apr;12(2):83. doi: 10.1016/j.jtos.2014.02.004. Epub 2014 Feb 15. No abstract available.

PMID:
24725319
12.

New testing options for diagnosing and grading dry eye disease.

Foulks GN, Pflugfelder SC.

Am J Ophthalmol. 2014 Jun;157(6):1122-9. doi: 10.1016/j.ajo.2014.03.002. Epub 2014 Mar 12.

13.

Old and new methods of evaluating the ocular surface.

Foulks GN.

Ocul Surf. 2014 Jan;12(1):1. doi: 10.1016/j.jtos.2013.10.006. Epub 2013 Nov 1. No abstract available.

PMID:
24439040
14.

The value of tear osmolarity as a metric in evaluating the response to dry eye therapy in the clinic and in clinical trials.

Pepose JS, Sullivan BD, Foulks GN, Lemp MA.

Am J Ophthalmol. 2014 Jan;157(1):4-6.e1. doi: 10.1016/j.ajo.2013.10.020. Epub 2013 Nov 9. No abstract available.

PMID:
24220266
15.

Re-examining dry eye disease.

Foulks GN.

Ocul Surf. 2013 Oct;11(4):211. doi: 10.1016/j.jtos.2013.08.001. Epub 2013 Aug 9. No abstract available.

PMID:
24112224
16.

The TFOS International Workshop on Contact Lens Discomfort: executive summary.

Nichols JJ, Willcox MD, Bron AJ, Belmonte C, Ciolino JB, Craig JP, Dogru M, Foulks GN, Jones L, Nelson JD, Nichols KK, Purslow C, Schaumberg DA, Stapleton F, Sullivan DA; members of the TFOS International Workshop on Contact Lens Discomfort.

Invest Ophthalmol Vis Sci. 2013 Oct 18;54(11):TFOS7-TFOS13. doi: 10.1167/iovs.13-13212. No abstract available.

17.

Efficacy of an artificial tear emulsion in patients with dry eye associated with meibomian gland dysfunction.

Sindt CW, Foulks GN.

Clin Ophthalmol. 2013;7:1713-22. doi: 10.2147/OPTH.S35833. Epub 2013 Aug 27.

18.

Current and future therapy of ocular surface disease.

Foulks GN.

Ocul Surf. 2013 Jul;11(3):143. doi: 10.1016/j.jtos.2013.05.001. Epub 2013 May 22. No abstract available.

PMID:
23838015
19.

Assaults to the ocular surface.

Foulks GN.

Ocul Surf. 2013 Apr;11(2):59. doi: 10.1016/j.jtos.2013.02.001. Epub 2013 Feb 6. No abstract available.

PMID:
23583040
20.

Biology of the ocular surface and how it can be measured.

Foulks GN.

Ocul Surf. 2013 Jan;11(1):1. doi: 10.1016/j.jtos.2012.10.001. Epub 2012 Oct 17. No abstract available.

PMID:
23321351
21.

Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications.

Sullivan BD, Crews LA, Messmer EM, Foulks GN, Nichols KK, Baenninger P, Geerling G, Figueiredo F, Lemp MA.

Acta Ophthalmol. 2014 Mar;92(2):161-6. doi: 10.1111/aos.12012. Epub 2012 Dec 28.

22.

Evaluation of tear osmolarity in non-Sjögren and Sjögren Syndrome dry eye patients with the TearLab system.

Lemp MA, Foulks GN, Pepose JS.

Cornea. 2013 Mar;32(3):379-81. doi: 10.1097/ICO.0b013e31826ef421. No abstract available.

PMID:
23095500
23.

Elevated immunoglobulin to tissue KLK11 in patients with Sjögren syndrome.

El Annan J, Jiang G, Wang D, Zhou J, Foulks GN, Shao H.

Cornea. 2013 May;32(5):e90-3. doi: 10.1097/ICO.0b013e31826a1e2e.

PMID:
23086370
24.

Ocular surface cell biology--from the light to the dark side.

Foulks GN.

Ocul Surf. 2012 Oct;10(4):199. doi: 10.1016/j.jtos.2012.08.005. Epub 2012 Aug 11. No abstract available.

PMID:
23084138
25.

Improving awareness, identification, and management of meibomian gland dysfunction.

Foulks GN, Nichols KK, Bron AJ, Holland EJ, McDonald MB, Nelson JD.

Ophthalmology. 2012 Oct;119(10 Suppl):S1-12. doi: 10.1016/j.ophtha.2012.06.064.

PMID:
23034341
26.

Contact lenses and the rate of evaporation measured in vitro; the influence of wear, squalene and wax.

Vishnubhatla S, Borchman D, Foulks GN.

Cont Lens Anterior Eye. 2012 Dec;35(6):277-81. doi: 10.1016/j.clae.2012.07.008. Epub 2012 Aug 17.

PMID:
22906863
27.

Regulation, re-evaluation, and regenerative approaches.

Foulks GN.

Ocul Surf. 2012 Jul;10(3):125. doi: 10.1016/j.jtos.2012.04.005. Epub 2012 May 9. No abstract available.

PMID:
22814640
28.

Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study.

Foulks GN, Borchman D, Yappert M, Kakar S.

Cornea. 2013 Jan;32(1):44-53. doi: 10.1097/ICO.0b013e318254205f.

29.

Wax-tear and meibum protein, wax-β-carotene interactions in vitro using infrared spectroscopy.

Faheem S, Kim SH, Nguyen J, Neravetla S, Ball M, Foulks GN, Yappert MC, Borchman D.

Exp Eye Res. 2012 Jul;100:32-9. doi: 10.1016/j.exer.2012.04.003. Epub 2012 Apr 28.

30.

Confocal microscopy of central toxic keratopathy.

Thornton IL, Foulks GN, Eiferman RA.

Cornea. 2012 Aug;31(8):934-6. doi: 10.1097/ICO.0b013e3181f7f109.

PMID:
22562061
31.

Tofacitinib (CP-690,550), a Janus kinase inhibitor for dry eye disease: results from a phase 1/2 trial.

Liew SH, Nichols KK, Klamerus KJ, Li JZ, Zhang M, Foulks GN.

Ophthalmology. 2012 Jul;119(7):1328-35. doi: 10.1016/j.ophtha.2012.01.028. Epub 2012 Apr 22.

PMID:
22525048
32.

New features, new vessels, and ongoing challenges.

Foulks GN.

Ocul Surf. 2012 Apr;10(2):55. doi: 10.1016/j.jtos.2012.02.002. Epub 2012 Feb 10. No abstract available.

PMID:
22482466
33.

Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study.

Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD.

Cornea. 2012 May;31(5):472-8. doi: 10.1097/ICO.0b013e318225415a.

PMID:
22378109
34.

Pain, prostheses, and prophylaxis.

Foulks GN.

Ocul Surf. 2012 Jan;10(1):1. doi: 10.1016/j.jtos.2012.01.001. Epub 2012 Jan 8. No abstract available.

PMID:
22330054
35.

Changes in human meibum lipid composition with age using nuclear magnetic resonance spectroscopy.

Borchman D, Foulks GN, Yappert MC, Milliner SE.

Invest Ophthalmol Vis Sci. 2012 Jan 31;53(1):475-82. doi: 10.1167/iovs.11-8341.

36.

Differences in human meibum lipid composition with meibomian gland dysfunction using NMR and principal component analysis.

Borchman D, Foulks GN, Yappert MC, Milliner SE.

Invest Ophthalmol Vis Sci. 2012 Jan 25;53(1):337-47. doi: 10.1167/iovs.11-8551.

37.

Reduced lipid, liquid, and limbal vascularization.

Foulks GN.

Ocul Surf. 2011 Oct;9(4):189. No abstract available.

PMID:
22023813
38.

Analysis of the composition of lipid in human meibum from normal infants, children, adolescents, adults, and adults with meibomian gland dysfunction using ¹H-NMR spectroscopy.

Shrestha RK, Borchman D, Foulks GN, Yappert MC, Milliner SE.

Invest Ophthalmol Vis Sci. 2011 Sep 21;52(10):7350-8. doi: 10.1167/iovs.11-7391.

39.

Optimizing evaluation of Lissamine Green parameters for ocular surface staining.

Hamrah P, Alipour F, Jiang S, Sohn JH, Foulks GN.

Eye (Lond). 2011 Nov;25(11):1429-34. doi: 10.1038/eye.2011.184. Epub 2011 Aug 12.

40.

BAK to basics.

Foulks GN.

Ocul Surf. 2011 Jul;9(3):139. No abstract available.

PMID:
21791188
41.

Tools of the trade.

Foulks GN.

Ocul Surf. 2011 Jul;9(3):115. No abstract available.

PMID:
21791185
42.

Quantification of human sebum on skin and human meibum on the eye lid margin using Sebutape®, spectroscopy and chemical analysis.

Ashraf Z, Pasha U, Greenstone V, Akbar J, Apenbrinck E, Foulks GN, Borchman D.

Curr Eye Res. 2011 Jun;36(6):553-62. doi: 10.3109/02713683.2011.574331.

PMID:
21591865
43.

Solutes, surgery and the ocular surface.

Foulks GN.

Ocul Surf. 2011 Apr;9(2):59. No abstract available.

PMID:
21545759
44.

The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee.

Nelson JD, Shimazaki J, Benitez-del-Castillo JM, Craig JP, McCulley JP, Den S, Foulks GN.

Invest Ophthalmol Vis Sci. 2011 Mar 30;52(4):1930-7. doi: 10.1167/iovs.10-6997b. Print 2011 Mar. Review. No abstract available.

45.

The international workshop on meibomian gland dysfunction: executive summary.

Nichols KK, Foulks GN, Bron AJ, Glasgow BJ, Dogru M, Tsubota K, Lemp MA, Sullivan DA.

Invest Ophthalmol Vis Sci. 2011 Mar 30;52(4):1922-9. doi: 10.1167/iovs.10-6997a. Review. No abstract available.

46.

Human meibum lipid conformation and thermodynamic changes with meibomian-gland dysfunction.

Borchman D, Foulks GN, Yappert MC, Bell J, Wells E, Neravetla S, Greenstone V.

Invest Ophthalmol Vis Sci. 2011 Jun 1;52(6):3805-17. doi: 10.1167/iovs.10-6514.

47.

Corneal innervation, blinking, and visual performance.

Foulks GN.

Ocul Surf. 2011 Jan;9(1):1. No abstract available.

PMID:
21338562
48.

Tear osmolarity in the diagnosis and management of dry eye disease.

Lemp MA, Bron AJ, Baudouin C, Benítez Del Castillo JM, Geffen D, Tauber J, Foulks GN, Pepose JS, Sullivan BD.

Am J Ophthalmol. 2011 May;151(5):792-798.e1. doi: 10.1016/j.ajo.2010.10.032. Epub 2011 Feb 18.

PMID:
21310379
49.

Confirmation of changes in human meibum lipid infrared spectra with age using principal component analysis.

Borchman D, Foulks GN, Yappert MC.

Curr Eye Res. 2010 Sep;35(9):778-86. doi: 10.3109/02713683.2010.490895.

PMID:
20795859
50.

Meibomian gland dysfunction: the past, present, and future.

Foulks GN, Borchman D.

Eye Contact Lens. 2010 Sep;36(5):249-53. doi: 10.1097/ICL.0b013e3181ef0d37. Review.

PMID:
20724853

Supplemental Content

Loading ...
Support Center